Title:
A 5-Culver Moyle Adamantane - 2- Ylamide derivative, its pharmacologically permissible salt, and a manufacturing method for the same
Document Type and Number:
Japanese Patent JP6045573
Kind Code:
B2
Abstract:
Provided are a novel derivative of 5-carbamoyl adamantan-2-yl amide of Formula (I), or a pharmaceutically acceptable salt thereof, and a pharmaceutical use thereof for inhibiting the activity of 11β-hydroxystreroid dehydrogenase type 1 (11b-HSD1) or for preventing and/or treating various diseases mediated by 11β-hydroxystreroid dehydrogenase type 1.
Inventors:
Jung, Kumin
Ryu, Jeongho
Lee, Yun Kyung
Moon, disk
Lee, Hye Sung
Lee, Song Jung
Oh, Gyeongsuk
Ryu, Jeongho
Lee, Yun Kyung
Moon, disk
Lee, Hye Sung
Lee, Song Jung
Oh, Gyeongsuk
Application Number:
JP2014514817A
Publication Date:
December 14, 2016
Filing Date:
June 11, 2012
Export Citation:
Assignee:
SK by Offer Mathewicals Company Limited
International Classes:
C07D207/34; A61K31/341; A61K31/381; A61K31/40; A61K31/42; A61K31/422; A61K31/4418; A61K31/4425; A61K31/47; A61P3/04; A61P3/06; A61P3/10; A61P9/10; A61P19/02; A61P43/00; C07D213/81; C07D213/89; C07D215/48; C07D215/60; C07D261/18; C07D307/68; C07D333/38; C07D401/04; C07D409/04; C07D413/04; C07D413/12; C07D417/04
Domestic Patent References:
JP2010180178A |
Foreign References:
WO2011139107A1 | ||||
WO2008142986A1 | ||||
WO2007114124A1 | ||||
WO2011049520A1 | ||||
WO2011059021A1 | ||||
WO2011068927A1 |
Attorney, Agent or Firm:
Ryu Iwatani